Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | 1779 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | BILIRUBIN (CAS# 635-65-4); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |